Raphael Pharmaceutical, Inc. (RAPH)
1.51
0.00 (0.00%)
USD |
OTCM |
Nov 03, 16:00
Raphael Pharmaceutical Shareholders Equity (Quarterly) : -1.885M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.885M |
| March 31, 2026 | -1.662M |
| December 31, 2025 | -1.433M |
| September 30, 2025 | -1.264M |
| June 30, 2025 | -1.048M |
| March 31, 2025 | -0.734M |
| December 31, 2024 | -0.742M |
| September 30, 2024 | -0.616M |
| June 30, 2024 | -0.29M |
| March 31, 2024 | -0.103M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.207M |
| September 30, 2023 | -0.075M |
| June 30, 2023 | -0.061M |
| March 31, 2023 | -0.009M |
| December 31, 2022 | 0.106M |
| September 30, 2022 | -0.062M |
| June 30, 2022 | 0.118M |
| March 31, 2022 | 0.103M |
| December 31, 2021 | |
| September 30, 2021 | -0.125M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| IM Cannabis Corp. | -3.904M |
| Teva Pharmaceutical Industries Ltd. | 7.753B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 35.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.007M |
| Total Liabilities (Quarterly) | 1.892M |
| Debt to Equity Ratio | -0.0228 |
| Current Ratio | 0.0032 |
| Net Debt Paydown Yield | 0.00% |